AL
SLB icon

Aspiriant LLC’s SLB Ltd SLB Stock Holding History

Aspiriant LLC’s Portfolio SLB Stock Details SLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
5,480
+509
+10% +$27.3K 0.01% 343
2026
Q1 		$255K Sell
4,971
-719
-13% -$34.9K 0.01% 302
2025
Q4 		$218K Buy
+5,690
New +$206K 0.01% 310
2018
Q4 		– Sell
-5,977
Closed -$366K – 250
2018
Q3 		$366K Sell
5,977
-1,367
-19% -$88K 0.03% 176
2018
Q2 		$492K Sell
7,344
-1,971
-21% -$135K 0.04% 160
2018
Q1 		$603K Buy
+9,315
New +$651K 0.05% 142
2017
Q4 		– Sell
-13,689
Closed -$955K – 164
2017
Q3 		$955K Sell
13,689
-4,688
-26% -$310K 0.08% 109
2017
Q2 		$1.21M Sell
18,377
-2,699
-13% -$193K 0.11% 102
2017
Q1 		$1.65M Sell
21,076
-2,311
-10% -$189K 0.14% 92
2016
Q4 		$1.96M Buy
23,387
+195
+0.8% +$16K 0.18% 75
2016
Q3 		$1.82M Sell
23,192
-930
-4% -$73.8K 0.18% 74
2016
Q2 		$2.08M Sell
24,122
-493
-2% -$37.8K 0.2% 72
2016
Q1 		$1.81M Buy
+24,615
New +$1.73M 0.17% 74
2015
Q3 		– Sell
-2,711
Closed -$234K – 119
2015
Q2 		$234K Buy
+2,711
New +$245K 0.02% 101

Other funds holding SLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Aspiriant LLC's SLB Position: Q2 2026 in Review

Aspiriant LLC increased its SLB Ltd (SLB) stake by 10% in Q2 2026, buying an estimated $27.3K and bringing the position to 5,480 shares worth $255K. The position accounts for 0.01% of the portfolio, ranked #343.

Aspiriant LLC first reported a position in SLB in Q2 2015 and has held it in 14 quarters since. The position peaked at $2.08M in Q2 2016. 1,695 funds tracked by Wall St. Rank hold SLB as of Q2 2026.

  • Aspiriant LLC held 5,480 shares of SLB Ltd worth $255K as of Q2 2026.
  • Aspiriant LLC bought 509 SLB Ltd shares in Q2 2026, an estimated $27.3K.
  • SLB Ltd made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #343 holding.
  • Aspiriant LLC first reported a position in SLB Ltd in Q2 2015 and has held it in 14 quarters since.
  • Aspiriant LLC's SLB Ltd position peaked at $2.08M in Q2 2016.
  • 1,695 funds tracked by Wall St. Rank held SLB Ltd as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.